Search

Author/Creator Balfour, Alison

1. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Issue 7 (3rd May 2011)

Authors:
Schlesinger, Naomi; Mysler, Eduardo; Lin, Hsiao-Yi; De Meulemeester, Marc; Rovensky, Jozef; Arulmani, Udayasankar; Balfour, Alison; Krammer, Gerhard; Sallstig, Peter; So, Alexander
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 7(2011)
Page Start:
1264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Differences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar. (3rd October 2019)

Authors:
von Richter, Oliver; Lemke, Lena; Haliduola, Halimuniyazi; Balfour, Alison; Zehnpfennig, Britta; Skerjanec, Andrej; Jauch-Lembach, Julia
Journal:
Expert opinion on biological therapy
Issue:
Volume 19:Number 10(2019)
Page Start:
1057
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long‐term Efficacy, Safety, and Immunogenicity Data From a Phase III Confirmatory Study Comparing GP2017, a Proposed Biosimilar, With Reference Adalimumab: 751. (October 2017)

Authors:
Blauvelt, Andrew; Lacour, Jean‐Phillippe; Fowler, Joseph F.; Schuck, Ellen; Jauch‐Lembach, Julia; Balfour, Alison; Leonardi, Craig L.
Journal:
American journal of gastroenterology
Issue:
Volume 112(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗